Biogen 4Q profit rises as sales increase
WESTON, Mass. (AP) — Drugmaker Biogen Idec Inc.'s fourth-quarter profit grew 25 percent on cost savings from job cuts and increasing sales of its multiple sclerosis treatments.
Biogen said its profit rose to $300.2 million, or $1.22 per share, from $240.3 million, or 99 cents per share. The company said it earned $1.51 per share if one-time costs and gains are excluded. Revenue increased 9 percent, to $1.33 bill...
You have selected to view an article that is older than 60 days. There are several ways to unlock access to NewsOK historical content.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
